HYPD
NASDAQ · Pharmaceuticals
Hyperion Defi Inc
$3.74
+0.03 (+0.81%)
Open$3.53
Previous Close$3.71
Day High$3.91
Day Low$3.51
52W High$17.18
52W Low$2.49
Volume—
Avg Volume899.3K
Market Cap52.29M
P/E Ratio—
EPS$-3.92
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+331.6% upside
Current
$3.74
$3.74
Target
$16.14
$16.14
$9.68
$16.14 avg
$20.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.47M | 4.90M | 5.01M |
| Net Income | -137,364,052 | -3,832,248,999 | 1.46M |
| Profit Margin | -5,570.6% | -82,538.4% | 29.2% |
| EBITDA | -134,511,364 | -3,873,168,857 | 1.99M |
| Free Cash Flow | — | — | 1.60M |
| Rev Growth | — | -84.0% | +22.0% |
| Debt/Equity | 0.19 | 1.59 | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |